Please enter both email and password to log in
|
|
You need to upgrade your Flash Player to view this content.
What's New?
New CME-certified case study now live!
CCMD Faculty Member James M. McKenney, PharmD, presents a case exploring the assessment and management of a patient with atherogenic dyslipidemia. Upon completion of the evaluation form, you'll earn 0.75 AMA PRA Category 1 Credit™ instantly!
|
CMDManagement™ Fall/Winter 2007 issue now available for CME credit
This issue of our award-winning newsletter explores the latest advances in managing global cardiovascular risk in special populations. Also featured: a case study underscoring the role of primary prevention in the high-risk patient and a patient-education handout offering tips on maintaining arterial health, with a spotlight on peripheral arterial disease.
|
The latest in clinical literature
New selections: The association between physical activity and cardiovascular event risk, featuring expert commentary from CCMD Faculty Member Ezra A. Amsterdam, MD; baseline characteristics of participants in JUPITER; impact of the metabolic syndrome on macro- and microvascular outcomes in type 2 diabetes in UKPDS; and much more.
|
New slides from our Virtual Conferences series
Download more than 60 slides from our Virtual Conference series, Managing Patients With Atherogenic Dyslipidemia: Beyond LDL-C. The slides, featuring a didactic presentation and a case study, underscore clinical approaches to reducing the cardiovascular risk inherent with atherogenic dyslipidemia.
|
Clinical Insights® in Lipid Management Issue 12 now available
Co-Editor and CCMD Education Council Member Peter Libby, MD, comments on results from the ENHANCE trial. Also featured: lipoprotein(a) levels are continuously associated with future CHD risk; very high levels of HDL-C and very large HDL particle size are associated with increased CV risk.
|
New drug treatment table for hypertension
Read and download this new table that organizes various pharmacologic treatment options for hypertension, including diuretics, adrenergic inhibitors, alpha- and beta-blockers, direct vasodilators, calcium channel blockers, ACE inhibitors, ARBs, and more.
|
In the News
Heart Attack Rehab Patients Walking With Mini ECG
Jul 20, 2008 -- Dr Charles Worringham of Queensland University of Technology's Institute of Health and Biomedical Innovation said the unique 'Cardiomobile' monitoring system, developed by Gold Coast company Alive Technologies, was being further developed and trialled together with QUT under an ARC Linkage Grant.
|
In Marfan Syndrome The Aorta Is Torn Apart
Jul 20, 2008 -- A severe complication of the Marfan syndrome is that the aorta may split and be torn apart. The patient can be protected if the syndrome is diagnosed and treated in good time. In the current edition of the Deutsches Arzteblatt International (Dtsch Arztebl Int 2008; 105[27]: 483-91), the human geneticist Mine Arslan-Kirchner from Hannover University Medical School and his coauthors present additional studies on Marfan patients.
|
|
|
|
|
CCMD Co-Chairmen
|
Education Council
George L. Bakris, MD
|
Elizabeth Barrett-Connor, MD
|
Keith C. Ferdinand, MD
|
JoAnne M. Foody, MD
|
Peter Ganz, MD
|
Philip B. Gorelick, MD, MPH
|
Scott M. Grundy, MD, PhD
|
Steven M. Haffner, MD
|
Ronald M. Krauss, MD
|
John C. LaRosa, MD
|
Peter Libby, MD
|
Thomas A. Pearson, MD, MPH, PhD
|
|
|